Email directly Dr. Zennadi at rahima.zennadi@duke.edu for position consideration.
A Postdoctoral position is available in the laboratory of Dr. Rahima Zennadi at Duke University. We are seeking to recruit a productive postdoctoral associate with a demonstrated potential to develop an independent research career. Candidates with skills in small non-coding RNA research and RNA biology and/or erythropoiesis are strongly encouraged to apply. The successful candidate will conduct independent studies in both cardiovascular and cerebrovascular sciences, utilizing cutting edge technologies to address significant clinical problems, including sickle cell disease, stroke, and Alzheimer’s disease. As such these projects are highly competitive for the postdoc to faculty transitional funding mechanisms at various agencies such as the NIH, NSF, and the AHA. The lab is very well funded and has been recognized for significant contributions to the field of sickle cell disease and aging. The Hematology division at Duke offers a highly diverse and collaborative academic environment with state of the art core facilities. For position consideration and to get more information about the position, please send curriculum vitae and contact info of references to: Rahima Zennadi, Ph.D at rahima.zennadi@duke.edu
Required qualifications:
1. A PhD or MD degree with extensive research training in the biological sciences
2. Skills in basic biology laboratory techniques including sterile techniques, and proper documentation/record-keeping
3. Experience in cell culture techniques including transfection and cell-based analysis of viability
4. Experience in molecular biology techniques including protein, RNA and DNA isolation and handling for applications including qPCR, and immune-blotting
Preferred qualifications:
1. Understanding or knowledge of human and murine hematopoiesis
2. Experience in murine erythroid progenitor cell isolation and maturation
3. Genome editing using CRISPR or similar techniques |
finished (2022/02/11, finished 2022/12/03, listed until 2022/08/11)